Effects of the Physical Therapy Treatment on Children and Adolescents With Chronic and Neurological Pathologies Affecting Their Sensorimotor Abilities.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Universidad de Almeria
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Motor Function Measure
Study Overview
Brief Summary
To evaluate the positive effects of a home-based physical therapy intervention added to the usual physical therapy programs performed in children with neurological pathologies that induce sensorimotor impairments that affect their quality of life and the importance of the implications of their families in their treatment.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Care Provider, Outcomes Assessor)
Eligibility Criteria
- Ages
- 3 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Parents agree to include their children on the study
- •Affiliated to the Duchenne Parents Project Association (Spain)
- •Between 3-18 years old
Exclusion Criteria
- •Other pathological conditions
- •Parents refuse the participation on the study
Arms & Interventions
Home-based Physiotherapy
Two days a week of physical therapy (mobilizations, manual therapy, stretching, respiratory techniques) + 3 hours extra of home-based physiotherapy (stretching, active mobilizations)
Intervention: Home-based physiotherapy (Other)
Usual physiotherapy
Two days a week of physical therapy (mobilizations, manual therapy, stretching, respiratory techniques)
Intervention: Usual Physiotherapy (Other)
Outcomes
Primary Outcomes
Motor Function Measure
Time Frame: One Year
Measurement scale for motor function applied to neuromuscular diseases (MFM): It was created in France in order to perform a better evaluation of global motor function in patients with Duchenne's muscular dystrophy (DMD), both for ambulatory and non-ambulatory patients. It has two versions, MFM 20 for children under 6 years of age and MFM 32 for children over 6 years of age. The scale considers three dimensions: (D1) standing station and transfers; (D2) axial and proximal motor skills and (D3) distal motor skills. The sum of the three results in a global percentage that provides an updated overview of the patient's functional diagnosis. (Trundell et al., 2020)
Secondary Outcomes
- Brooke Upper Extremity Scale(One Year)
- Vignos Scale(One Year)
- Timed Up and Go Test(One Year)
- Six Minutes Walk Distance(One Year)
Investigators
María del Mar Sánchez Joya
Associate Professor
Universidad de Almeria